This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Yi Yang, PhD
Lead Scientist at Ferring Pharmaceuticals A/S
Speaker

Profile

Dr. Yi Yang obtained his Ph.D degree from Bielefeld University, Germany, in 2008 under the guidance of Prof. Dr. Norbert Sewald. He has been working at Lonza in Visp/Switzerland as a process chemist for peptide API process development, optimization, innovation, and GMP manufacturing. He is now working at Ferring Pharmaceuticals A/S as a lead scientist, focusing on the peptide API process development, optimization, innovation, and the management of the GMP manufacturing. Dr. Yi Yang has abundant experiences on peptide synthesis, side reaction/impurity analysis from both API manufacturing and formulation, process development/optimization/validation through QbD (Quality-by-Design), innovation, and GMP manufacturing including genotoxic impurity management, tech-transfer, risk assessment, operation, and regulatory management. Dr. Yi Yang holds a Lean-Six-Sigma Black Belt Certificate and published many articles as well as a monograph of “Side Reactions in Peptide Synthesis” (Academic Press).

Agenda Sessions

  • Optimizing Critical Peptide Impurity Management through Design of Experiments

    16:45